Upregulation of spondin-2 indicates poorer clinical outcomes and induces radioresistance in gastric cancer
Yongqin Zhang, Yun Zuo, Dong Hua · 2025
Read Upregulation of spondin-2 indicates poorer clinical outcomes and induces radioresistance in gastric cancer by Yongqin Zhang, Yun Zuo, Dong Hua (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12776211.txt.
Description
Yongqin Zhang, Yun Zuo, and Dong Hua link a protein called spondin-2 to gastric cancer outcomes in this 2025 paper. Spondin-2 is raised in several cancers and tied to spread. Its role in stomach cancer, and in radiation response, was unclear.
Public data showed far more spondin-2 in tumor tissue than in healthy stomach lining. High levels tracked larger tumors and shorter survival. Cell tests in a gastric cancer line showed the protein drives growth and migration. Extra spondin-2 also made cells resist radiation. It blunted cell cycle arrest, death, and DNA damage after exposure. The authors propose it as a marker for radiotherapy response.
Catalog record
| CREATOR | Yongqin Zhang, Yun Zuo, Dong Hua |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |